Transcatheter mitral valve implantation: different fi xation techniques

Georg Lutter, Derk Frank, Jan Hinnerk Hansen, Yazhou Liu, Jochen Cremer, Assad Haneya,

Thomas Puehler1

1Department of Cardiovascular Surgery, University of Kiel, School of Medicine, Kiel 24105, Germany.

2Department of Cardiology and Angiology, Christian-Albrechts-University of Kiel, Kiel 24105, Germany.

3Department of Pediatric Cardiology, University of Kiel, School of Medicine, Kiel 24105, Germany.

Abstract Transcatheter mitral valve implantation provides an off-pump treatment option for mitral valve regurgitation,especially for secondary mitral regurgitation. It offers an opportunity for the treatment of a large cohort of patients not referred for conventional surgery. One of the biggest challenges is the development of a valved stent that suits the complex anatomy of the native mitral valve. Furthermore, secure anchorage of the device is difficult in the mitral area without clearly defined structures. In the last few years, various new self-expanding nitinol valved stents for transapical implantation in the beating heart have been developed. Different design iterations were conducted to improve fixation and overall stent performance. The risk of paravalvular leakage was decreased and reproducibility enhanced. This article reviews the major achievements in the development process of our apically fixed mitral valved stent over the last few years, with prototypes that provide secure stent deployment, high reproducibility and low paravalvular leakage rates.

Keywords: Mitral valve, transcatheter, valved stent, off-pump, fixation techniques

INTRODUCTION

The development of transcatheter mitral valve implantation is the focus of recent research. This novel procedure provides a means to treat severe and symptomatic mitral insufficiency, especially secondary mitral regurgitation, without the need for ECMO during surgery. The transcatheter mitral valve implantation device includes heart valved stents that are implanted into the beating heart using a transcatheter-guided technique.This novel technology is ideal, especially for older patients, who are classified as high-risk patients or not operable. Due to the advanced age and severe comorbidities, approximately 49% of patients suffering from severe and symptomatic mitral valve insufficiency are not candidates for open-heart surgery[1].

Challenges in the development process of such mitral valved stents include: high pressure within the left heart chamber, secure fixation to the complex anatomy of the mitral valve apparatus, absence of left ventricular outf l ow tract obstruction, and a tight seal to prevent the occurrence of paravalvular leakage after valved stent implantation. Due to very high pressures within the left ventricle, which act on the closed mitral valve, the development of strong systolic fi xation of the device to prevent migration into the left atrium is of particular importance during the research and developmental process.

TETHERED APICAL FIXATION (LUTTER VALVE)

The fi rst implantations of an apically tethered transcatheter mitral valve were reported in fi ve studies between 2008 and 2013. The device was made of a self-expanding nitinol stent with a tubular ventricular part and an atrial cuff. The stent was covered with a polytetraf l uoroethylene membrane and carried a trileaf l et bovine pericardial valve [Figure 1]. In total, 36 pigs received off-pump mitral valved stent implantation with this device. Seventeen pigs were followed up for 1 h after implantation[2-4], one animal for 6 h, four animals for 1 week[5], fi ve animals for 1 month, four animals for 2 months and one animal for 3 months[6,7]. Six animals died during the surgery or within the fi rst hours after implantation: two suffered from ventricular fi brillation,two died from prosthesis mispositioning and two from incorrect fi xation.

Transesophageal echocardiography (TEE) and computed tomography (CT) were used to evaluate stent function and correct positioning. Seven of 32 animals showed mild regurgitation after mitral valved stent implantation and a few stent fractures were observed after post-mortem valve explantation. Nevertheless,no valve stent migration, embolization, systolic anterior movement or left ventricular outflow tract obstruction was observed in the surviving animals. Gross evaluation revealed tissue coverage of the atrial element of the stent after four to eight weeks and the new, apically-tethered mitral valved stent showed good overall valve function in all cases after two and three months. These fi rst studies demonstrated the feasibility of a reproducible method of deployment of the mitral valved stent with low gradients across the left ventricular outf l ow tract, and adequate stent function for up to three months in a large animal model.

COMPUTED TOMOGRAPHIC EVALUATION OF DIFFERENT PROTOTYPE DESIGNS

The in vivo shaping of mitral valved stent prototypes composed of a tubular ventricular body connected to an atrial element at different angles (45°, 90°, 110°) was evaluated using CT in 11 pigs[8]. CT was successfully carried out 3 weeks after implantation and stent shaping, as well as left ventricular outf l ow tract obstruction,was controlled [Figure 2] and stent position was correct in all animals. Nevertheless, stent body deformations at the atrio-ventricular junction were detected in all cases, with the biggest def l ection of the prototypes at an angle of 45°. A larger preset angle demonstrated less def l ection and improved the alignment, thus reducing the mechanical load on the stent. Obstruction of the outf l ow tract was observed in two animals[8].

APICAL FIXATION FORCES

To estimate the quantification of apical fi xation forces of a tethered mitral valved stent, a study was carried out by Pokorny et al.[9]. With a specifically designed test setup, the forces acting on the apical fi xation tethers were successfully measured in 18 animals [Figure 3]. The apical fi xation forces were recorded following off-pump mitral valved stent implantation. In this study, two different stent designs were used. The fi rst group(n = 10) had a sole apical fixation and the second (n = 8) had additional sub-annular fixation. The mean fixation forces were higher in the former and a significant reduction of the force acting on the apex was achieved with the latter[9].

Figure 1. A: ventricular view of the atrioventricular valved stent. It consists of a bovine pericardial valve of 27 mm diameter, a custommade nitinol stent, and a ventricular fixation system consisting of the annular radial force of the nitinol stent and four tethers fixed at the apex; B: atrial view of the prototype valved stent[3]; C: ventricular view of the new refined mitral valved stent; D: operative setting after ministernotomy (2 inches) with this valved stent and apex of the heart with purse-string sutures is exposed[6]

Figure 2. A-C: cardiac CT short- and long-axis standard views showing correct stent position and no left ventricular outflow tract obstruction of the 110° prototype 1 month after implantation; D: three-dimensional reconstruction showing the nitinol stent frame and left atrial and ventricular volumes. Reprinted from EuroIntervention, Pokorny et al.[8], Transapical mitral valved stent implantation: computed tomographic evaluation of different prototype designs, 948-955. Copyright (2015), with permission from Europa Digital & Publishing. Ao:aorta; LA: left atrium; LV: left ventricle (white arrow indicates the nitinol stent frame)

SUB-ANNULAR FIXATION

Figure 3. Illustration of the force measurement system developed: (a) schematic diagram of the test set-up; (b) lateral view of the test set-up during force quantification after mitral valved stent implantation; (c) frontal view of the FS connected to the NC via the CE. S:stent; NC: neo-chords; FS: force sensor; CE: connecting element; B: fixation bridge; C: computer for digital data recording[10]

Figure 4. Illustration of the mitral valved stent prototypes with apical and additional sub-annular fixation elements (red arrows),comprising atrial element (LA), ventricular body (LV) and BV. The AF points are indicated by dots. A and B: apical view; C and D:ventricular view of the prototype SA with additional subannular fixation; E and F: lateral view of the prototype SA12. LA: left atrium; LV:left ventricle; BV: bioprosthetic heart valve; AF: apical fixation; MA: mitral annulus; SA: sub-annular

A mitral valved stent with apical and additional sub-annular fixation was presented in a study in 2016[Figure 4][10]. Ten pigs received off-pump mitral valved stent implantation of this novel design. Acute TEE and haemodynamic evaluations were assessed 60 min post implantation. Haemodynamic stability, low gradients and physiological longitudinal function were achieved. In nine cases, paravalvular leakage was trace or less. Furthermore, decreased ejection fraction, several stent fractures and an overall lower survival time compared to sole apical fi xation were observed with this fi xation method[11].

SUPRA-ANNULAR FIXATION

Figure 5. A: mitral valved stent with apical and additional supra-annular fixation elements; B: hook shaped elements; C: mitral valved stent with apical and subsequent sub-valvular fixation rim[13]

Special small fixation hooks were developed and fabricated and a supra-annular fixation method was established. These hooks were mounted on the atrial part of the mitral stent to penetrate into the surrounding annular tissue to serve as an additional fixation [Figure 5A and B][10]. In anin vivostudy with fi ve pigs, stents were equipped with three (n= 2) or four hooks (n= 3) as well as four neo-chords for apical fi xation and implanted in an off-pump procedure. A thread system enabled successful deployment of the hooks within the heart in four of fi ve cases. One animal died within hours after implantation due to a prosthesis mismatch; one animal was sacrificed after two weeks; three animals were followed up to 1 month; and one animal was followed to three months with excellent health. Good valve function as well as normal left ventricular function was demonstrated by TEE and haemodynamic evaluation[11].

SUB-VALVULAR FIXATION

A modified nitinol valved stent with a ventricular rim was developed for sub-valvular fi xation [Figure 5C].For secure fi xation, an additional apical fi xation system was attached to these stents[11]. This prototype was successfully implanted in an off-pump procedure in ten animals. A higher degree of ventricular fi brillation occurred in this group. In four of ten cases, multiple areas of infarction, arrhythmia and in one case,persistent atrial fi brillation was observed after valved stent implantation. Eight animals died within the fi rst day of implantation. The other two animals were weaned from anaesthesia and followed up for a period of two and seven days. Nevertheless, a reduction in left ventricular ejection fraction compared to baseline values was also observed in this study group.

CONCLUSION

The correct positioning and sufficient fi xation of a transcatheter mitral valved stent is a challenging task and the topic of several studies and developments in recent years. Our group specializes in the development of apical fi xation methods and itsin vivoevaluation. Different fi xation techniques such as sole apical fi xation and a combination of apical fi xation with sub-annular, supra-annular or sub-valvular fi xation have been presented in this review.

Even though sole apical fixation showed promising results in animal studies and already has very good results in clinical studies with the Tendyne mitral valve prosthesis in more than 150 patients (mainly in the USA and Australia), fi xation force measurements demonstrated the advantage of a combined fi xation strategy. In the meantime, the latter received the CE mark in March 2020. Though transseptal implantation of the mitral valved stent through the femoral access site is less invasive and expected, transapical left ventricular implantation is, at the moment, the only route to deliver the whole material to the mitral anulus and allow additional secure fi xation. Perhaps smaller valve prostheses and newer fi xation techniques will allow transfemoral access in the future. Consequently, different combinations of fixation concepts are continuously under development in large animal and pre-clinical studies. To succeed,in vivoquantification of mechanical deformations of the stent by CT should be performed after implantation to identify critical areas in stent design. Finally, the alignment and reduction of mechanical stress on the stent frame should be topics for further stent frame development.

DECLARATIONS

Authors’ contributions

Wrote the manuscript and invented the stent prosthesis: Lutter G

Drafted the manuscript and substantially revised it: Frank D, Hansen JH, Cremer J

Contributed tot he conception and design of the studies and performed data analysis and interpretation ofthe data, they drafted the manuscript and substantially revised it: Liu Y, Haneya A, Puehler T

Availability of data and materials

Not applicable.

Financial support and sponsorship

These projects were supported by the German Research Foundation (DFG) and the German Centre for Cardiovascular Research (DZHK).

Conflicts of interest

Prof. Georg Lutter and Prof. Derk Frank: consultants to Abbott, Edwards and Medtronic. All other authors have nothing to disclose.

Ethical approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Copyright

© The Author(s) 2020.